Skip to main content

Advertisement

Log in

Neurosarcoidosis

  • Neuroimmunology
  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References and Recommended Reading

  1. Mayer S, Yim G, Onesti S, et al.:Biopsy-proven isolated sarcoid meningitis.J Neurosurg 1993, 78:994–996.

    Article  PubMed  CAS  Google Scholar 

  2. Agbogu B, Stern B, Sewell C, et al.:Therapeutic considerations in patients with refractory neurosarcoidosis.Arch Neurol 1995, 52:875–879.

    PubMed  CAS  Google Scholar 

  3. Scott T:Neurosarcoidosis: progress and clinical aspects.Neurology 1993, 43:8–12.

    PubMed  CAS  Google Scholar 

  4. Chapelon-Abric C, de Zuttere D, Duhaut P, et al.:Cardiac sarcoidosis—a retrospective study of 41 cases.Medicine (Baltimore) 2004, 83:315–334.

    Article  Google Scholar 

  5. Delaney P:Neurologic manifestations in sarcoidosis.Ann Intern Med 1977, 87:336–345.

    PubMed  CAS  Google Scholar 

  6. Vourlekis J, Sawyer R, Newman L:Sarcoidosis: developments in etiology, immunology and therapeutics.Adv Intern Med 2000, 45:209–257.

    PubMed  CAS  Google Scholar 

  7. McGrath D, Daniil Z, Foley B, et al.:Epidemiology of familial sarcoidosis in the UK.Thorax 2000, 55:751–754.

    Article  PubMed  CAS  Google Scholar 

  8. Of importance Hoitsma E, Faber G, Dent M et al.:Neurosarcoidosis: a clinical dilemma.Lancet Neurol 2004, 3:397–407. Excellent recent update and review of diagnosis of neurosarcoid.

    Article  PubMed  Google Scholar 

  9. Stern B:Neurosarcoidosis Neurol Chron 1992, 2:1–6.

    Google Scholar 

  10. Constantino T, Digre K, Zimmerman P:Neuro-ophthalmic complications of sarcoidosis.Semin Neurol 2000, 20:123–137.

    Article  PubMed  CAS  Google Scholar 

  11. Castellano-Sanchez A:Extensive leptomeningeal and intraparenchymatous spinal cord neurosarcoidosis.South Med J 2000, 93:815–817.

    PubMed  CAS  Google Scholar 

  12. Zajicek J, Scolding N, Foster O, et al.:Central nervous system sarcoidosis—diagnosis and management.Q J Med 1999, 92:103–117.

    CAS  Google Scholar 

  13. Of importance Marangoni S, Argentiero V, Tavolto B:Neurosarcoidosis: clinical description of 7 cases with a proposal for a new diagnostic strategy.J Neurol 2006, 253:488–495. Proposes a new diagnosis strategy.

    Article  PubMed  Google Scholar 

  14. Dumas J, Valeyre D, Chapelon-Abric C, et al.:Central nervous system sarcoidosis: follow-up at MRI during steroid therapy.Radiology 2000, 214:411–420.

    PubMed  CAS  Google Scholar 

  15. Handler M, Johnson L, Dick A, et al.:Neurosarcoidosis with unusual MRI findings.Neuroradiology 1993, 35:146–148.

    Article  PubMed  CAS  Google Scholar 

  16. Borucki S, Nguyen B, Ladoulis C, et al.:Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis.Arch Neurol 1989, 46:270–273.

    PubMed  CAS  Google Scholar 

  17. Oksanen V, Fyhrquist F, Somer H, et al.:Angiotensin-converting enzyme in cerebral fluid.Neurology 1985, 35:1220–1223.

    PubMed  CAS  Google Scholar 

  18. Dale J, O’Brien J:Determination of angiotension-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis.Mayo Clin Proc 1999, 74:535.

    PubMed  CAS  Google Scholar 

  19. Stern B, Griffin D, Luke R, et al.:Neurosarcoidosis cerebrospinal fluid lymphocyte subpopulations.Neurology 1987, 37:878–881.

    PubMed  CAS  Google Scholar 

  20. Hoitsma E, Marziniak M, Faber CG, et al.:Small fiber neuropathy in sarcoidosis.Lancet 2002, 359:2085–2086.

    Article  PubMed  CAS  Google Scholar 

  21. Reed L, Abbas S, Markivee C, et al.:Neurosarcoidosis responding to steroids.AJR Am J Roentgenol 1986, 146:819–821.

    PubMed  CAS  Google Scholar 

  22. Baughman R, Winget D, Lower E:Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:60–66.

    PubMed  CAS  Google Scholar 

  23. Doty J, Mazur J, Judson M:Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen.Chest 2003, 124:2023–2026.

    Article  PubMed  Google Scholar 

  24. Weiner H, Mackin G, Orav E, et al.:Intermittent cyclo-phosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.Neurology 1993, 43:910–918.

    PubMed  CAS  Google Scholar 

  25. Boumpas D, Yamada H, Patronas N, et al.:Pulse cyclophosphamide for severe neuropsychiatric lupus.Q J Med 1991, 81:975–984.

    PubMed  CAS  Google Scholar 

  26. Stern B, Schonfeld A, Sewell C, et al.:The treatment of neurosarcoidosis with cyclosporine.Arch Neurol 1992, 49:1063–1072.

    Google Scholar 

  27. Bielory L, Holland C, Gascon P, et al.:Uveitis, cutaneous and neurosarcoid: treatment with low-dose cyclosporine A.Transplant Proc 1988, 20:144–148.

    PubMed  CAS  Google Scholar 

  28. Doty J, Mazur J, Judson M:Treatment of neurosarcoidosis with infliximib.Chest 2005, 127:1064–1071.

    Article  PubMed  CAS  Google Scholar 

  29. Pettersen J, Zochodne D, Bell B, et al.:Refractory neurosarcoidosis responding to infliximb.Neurology 2002, 59:1660–1661.

    Article  PubMed  CAS  Google Scholar 

  30. Sollberger M, Fluri F, Baumann T, et al.:Successful treatment of steroid-refractory neurosarcoidosis with infliximab.J Neurol 2004, 251:760–761.

    Article  PubMed  CAS  Google Scholar 

  31. Katz J, Bruno M, Winterkorn J, et al.:The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximib.Arch Neurol 2003, 60:426–430.

    Article  PubMed  Google Scholar 

  32. Carter J, Valeriano J, Vasey F, et al.:Refractory neurosarcoidosis: a dramatic response to infliximib.Am J Med 2004, 117:277–279.

    Article  PubMed  Google Scholar 

  33. Sharma O:Effectiveness of chloroquine and hydroxyl-chloroquine in treating selected patients with sarcoidosis with neurological involvement.Arch Neurol 1998, 55:1248–1254.

    Article  PubMed  CAS  Google Scholar 

  34. Bruns F, Pruemer B, Haverkamp U, et al.:Neurosarcoidosis: an unusual indication for radiotherapy.Br J Radiol 2004, 77:777–779.

    Article  PubMed  CAS  Google Scholar 

  35. Bejar I, Kerby G, Ziegler D, et al.:Treatment of central nervous system sarcoidosis with radiotherapy.Ann Neurol 1985, 18:258–260.

    Article  PubMed  CAS  Google Scholar 

  36. Menninger M, Amdur R, Marcus R Jr:Role of radiotherapy in the treatment of neurosarcoidosis.Am J Clin Oncol 2003, 26:e115-e118.

    Article  PubMed  Google Scholar 

  37. Kingsley D, Kendall B:CT of the adverse effects of therapeutic radiation of the central nervous system.AJNR Am J Neuroradiol 1981, 2:453–460.

    PubMed  CAS  Google Scholar 

  38. Fried E, Landau A, Sher J, et al.:Spinal cord sarcoidosis: a case report and review of the literature.J Assoc Acad Minor Phys 1993, 4:132–137.

    PubMed  CAS  Google Scholar 

  39. Hesselmann V, Wedekind C, Terstegge K, et al.:An isolated fourth ventricle in neurosarcoidosis: MRI findings.Eur Radiol 2002, 12:S1-S3.

    Article  PubMed  Google Scholar 

  40. Foley K, Howell J, Junck L:Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis.Postgrad Med J 1989, 65:481–484.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William R. Tylor MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, A.V., Stickler, D.E. & Tylor, W.R. Neurosarcoidosis. Curr Treat Options Neurol 9, 161–168 (2007). https://doi.org/10.1007/BF02938405

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938405

Keywords

Navigation